Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.19 USD
Change Today -0.12 / -1.90%
Volume 770.7K
OSUR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen R. Lee Ph.D.

Former Chief Science Officer and Executive Vice President of Research and Development, OraSure Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54--
As of Fiscal Year 2013

Background*

Dr. Stephen R. Lee, also known as Steve, Ph.D. served as the Chief Science Officer and Executive Vice President of Research and Development at OraSure Technologies, Inc. from September 26, 2005 to February 28, 2014. Dr. Lee has more than 25 years of experience in the immunodiagnostic industry and joined OraSure from Ortho-Clinical Diagnostics, a Johnson & Johnson company. While at Ortho-Clinical Diagnostics, he served as Vice President of Assay Research & Development, ...

Read Full Background

Corporate Headquarters*

220 East First Street
Bethlehem, Pennsylvania 18015

United States

Phone: 610-882-1820
Fax: 610-882-1830

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1985
University of Cardiff
BS 1981
The University of Sheffield

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $6.19 USD -0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
$524.4K
Paul Averback M.D., DABPFounder, Chairman, Chief Executive Officer, President and Member of Communications Committee
Nymox Pharmaceutical Corporation
$290.0K
John J. Sperzel III, B.Sc.Chief Executive Officer, President and Director
Chembio Diagnostics, Inc.
$298.6K
Raymond F. Akers Jr., Ph.D.Co-Founder, Executive Chairman, Chief Executive Officer, President and Secretary
Akers Biosciences Inc.
$394.2K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
$814.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.